KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Short term Debt: 2011-2025

Historic Short term Debt for Supernus Pharmaceuticals (SUPN) over the last 6 years, with Sep 2025 value amounting to $11.2 million.

  • Supernus Pharmaceuticals' Short term Debt fell 75.88% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year decrease of 75.88%. This contributed to the annual value of $47.3 million for FY2024, which is 9.08% down from last year.
  • According to the latest figures from Q3 2025, Supernus Pharmaceuticals' Short term Debt is $11.2 million, which was down 62.55% from $30.0 million recorded in Q1 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Short term Debt ranged from a high of $401.4 million in Q3 2022 and a low of $11.2 million during Q3 2025.
  • Moreover, its 3-year median value for Short term Debt was $46.9 million (2024), whereas its average is $43.1 million.
  • In the last 5 years, Supernus Pharmaceuticals' Short term Debt skyrocketed by 1,603.17% in 2022 and then crashed by 94.83% in 2023.
  • Quarterly analysis of 5 years shows Supernus Pharmaceuticals' Short term Debt stood at $44.8 million in 2021, then crashed by 52.90% to $21.1 million in 2022, then skyrocketed by 146.54% to $52.1 million in 2023, then dropped by 9.08% to $47.3 million in 2024, then crashed by 75.88% to $11.2 million in 2025.
  • Its Short term Debt stands at $11.2 million for Q3 2025, versus $30.0 million for Q1 2025 and $47.3 million for Q4 2024.